Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Mar-09 2:56 PM View:  | Andreatta Robert E CONTROLLER & CAO | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 834 | $95.00 | $79,230.00 | (40%) 2.1K to 1.26K | < 1% |
| 30-Mar-09 9:37 PM View: | Tessier-Lavigne Marc EVP, RESEARCH DRUG DISCOVERY | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 1,159 | $95.00 | $110,105.00 | (100%) 1.16K to 0 | < 1% |
| 20-Apr-09 6:07 PM View: | Yang Patrick Y EVP, Product Operations | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 1,746 | $95.00 | $165,870.00 | (42%) 4.18K to 2.43K | < 1% |
| 30-Mar-09 9:46 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 9,566 | $95.00 | $908,770.00 | (100%) 9.57K to 0 | < 1% |
| 30-Mar-09 9:45 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 5,766 | $95.00 | $547,770.00 | (100%) 5.77K to 0 | < 1% |
| 31-Mar-09 2:55 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 963 | $95.00 | $91,485.00 | (100%) 0.96K to 0 | < 1% |
| 31-Mar-09 2:56 PM View: | Andreatta Robert E CONTROLLER & CAO | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 1,263 | $95.00 | $119,985.00 | (100%) 1.26K to 0 | < 1% |
| 20-Apr-09 6:07 PM View: | Yang Patrick Y EVP, Product Operations | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 1,866 | $95.00 | $177,270.00 | (77%) 2.43K to 0.57K | < 1% |
| 30-Mar-09 9:51 PM View: | Ebersman David A EVP & CHIEF FINANCIAL OFFICER | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 3,641 | $95.00 | $345,895.00 | (42%) 8.62K to 4.98K | < 1% |
| 30-Mar-09 9:59 PM View: | Boyer Herbert W Ph D Director | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 27,500 | $95.00 | $2,612,500.00 | (100%) 27.5K to 0 | < 1% |
| 30-Mar-09 9:37 PM View: | Barron Hal SVP - DEVELOPMENT & CMO | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 1,740 | $95.00 | $165,300.00 | (100%) 1.74K to 0 | < 1% |
| 20-Apr-09 6:07 PM View: | Yang Patrick Y EVP, Product Operations | Genentech Inc. (DNA) | 26-Mar-09 | Gift | 568 | -- | -- | (100%) 0.57K to 0 | |
| 31-Mar-09 2:55 PM View: | Sanders Charles A Director | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 2,000 | $95.00 | $190,000.00 | (100%) 2.0K to 0 | < 1% |
| 30-Mar-09 9:44 PM View: | Desmond Hellmann Susan D PRESIDENT, | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 1,639 | $95.00 | $155,705.00 | (100%) 1.64K to 0 | < 1% |
| 30-Mar-09 9:51 PM View: | Ebersman David A EVP & CHIEF FINANCIAL OFFICER | Genentech Inc. (DNA) | 26-Mar-09 | Disposition | 4,977 | $95.00 | $472,815.00 | (100%) 4.98K to 0 | < 1% |
| 20-Jan-09 8:24 PM View: | Ebersman David A EVP & CHIEF FINANCIAL OFFICER | Genentech Inc. (DNA) | 15-Jan-09 | Gift | 122 | -- | -- | 1% 8.51K to 8.63K | |
| 20-Jan-09 8:24 PM View: | Ebersman David A EVP & CHIEF FINANCIAL OFFICER | Genentech Inc. (DNA) | 15-Jan-09 | Gift | 122 | -- | -- | (1%) 8.63K to 8.51K | |
| 23-Jul-08 2:37 PM View: | Yang Patrick Y EVP-PRODUCT OPERATIONS | Genentech Inc. (DNA) | 21-Jul-08 | Option Exercise | 50,000 | $43.36 | $2,168,000.00 | 1292% 3.87K to 53.87K | 79% |
| 23-Jul-08 2:37 PM View: | Yang Patrick Y EVP-PRODUCT OPERATIONS | Genentech Inc. (DNA) | 21-Jul-08 | Market Option Sale | 50,000 | $92.98 | $4,649,000.00 | (93%) 53.87K to 3.87K | (< 1%) |
| 22-Jul-08 1:34 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Option Exercise | 21,629 | $12.13 | $262,360.00 | 233% 9.27K to 30.9K | 541% |
| 22-Jul-08 1:37 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Option Exercise | 27,249 | $12.13 | $330,530.00 | 294% 9.27K to 36.52K | 541% |
| 22-Jul-08 1:34 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Market Option Sale | 21,629 | $81.05 | $1,753,060.00 | (70%) 30.9K to 9.27K | (16%) |
| 22-Jul-08 1:37 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Market Option Sale | 27,249 | $80.82 | $2,202,160.00 | (75%) 36.52K to 9.27K | (16%) |
| 22-Jul-08 1:33 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 18-Jul-08 | Option Exercise | 4,300 | $42.05 | $180,815.00 | 79% 5.47K to 9.77K | 85% |
| 22-Jul-08 1:33 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 18-Jul-08 | Market Option Sale | 4,300 | $81.97 | $352,464.00 | (44%) 9.77K to 5.47K | (14%) |
| 22-Jul-08 1:35 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Option Exercise | 30,670 | $12.13 | $372,027.00 | 331% 9.27K to 39.94K | 541% |
| 22-Jul-08 1:35 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Market Option Sale | 30,670 | $80.72 | $2,475,670.00 | (77%) 39.94K to 9.27K | (16%) |
| 22-Jul-08 1:36 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Option Exercise | 10,452 | $12.13 | $126,783.00 | 113% 9.27K to 19.72K | 541% |
| 22-Jul-08 1:36 PM View: | Levinson Arthur D CHAIRMAN & CEO Director | Genentech Inc. (DNA) | 18-Jul-08 | Market Option Sale | 10,452 | $80.66 | $843,052.00 | (53%) 19.72K to 9.27K | (16%) |
| 22-Jul-08 1:31 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 18-Jul-08 | Option Exercise | 20,700 | $42.05 | $870,435.00 | 379% 5.47K to 26.17K | 85% |
| 22-Jul-08 1:31 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 18-Jul-08 | Market Option Sale | 20,700 | $82.12 | $1,699,910.00 | (79%) 26.17K to 5.47K | (14%) |
| 18-Jul-08 12:34 PM View: | Scheller Richard H EVP-RESEARCH | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 4,167 | $53.23 | $221,809.00 | 100% 0 to 4.17K | 46% |
| 18-Jul-08 4:37 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 16,634 | $42.05 | $699,460.00 | 304% 5.47K to 22.1K | 85% |
| 18-Jul-08 12:35 PM View: | Desmond Hellmann Susan D PRESIDENT, | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 28,743 | $20.90 | $600,729.00 | 1754% 1.64K to 30.38K | 272% |
| 18-Jul-08 4:20 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 18,124 | $42.05 | $762,114.00 | 2713% 0.67K to 18.79K | 85% |
| 18-Jul-08 4:37 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 16-Jul-08 | Market Option Sale | 16,634 | $79.31 | $1,319,300.00 | (75%) 22.1K to 5.47K | (18%) |
| 18-Jul-08 4:22 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 17,800 | $53.23 | $947,494.00 | 1839% 0.97K to 18.77K | 46% |
| 18-Jul-08 4:21 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Market Option Sale | 15,756 | $80.00 | $1,260,430.00 | (87%) 18.02K to 2.27K | (17%) |
| 18-Jul-08 4:22 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Market Option Sale | 30,817 | $80.35 | $2,476,100.00 | (94%) 32.88K to 2.07K | (17%) |
| 18-Jul-08 12:33 PM View: | Tessier-Lavigne Marc EVP, RESEARCH DRUG DISCOVERY | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 18,750 | $53.23 | $998,062.00 | 1618% 1.16K to 19.91K | 46% |
| 18-Jul-08 4:37 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 8,366 | $42.05 | $351,790.00 | 153% 5.47K to 13.83K | 85% |
| 18-Jul-08 12:35 PM View: | Desmond Hellmann Susan D PRESIDENT, | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 21,257 | $20.90 | $444,271.00 | 1297% 1.64K to 22.9K | 272% |
| 18-Jul-08 12:35 PM View: | Desmond Hellmann Susan D PRESIDENT, | Genentech Inc. (DNA) | 16-Jul-08 | Market Option Sale | 28,743 | $79.69 | $2,290,520.00 | (95%) 30.38K to 1.64K | (18%) |
| 18-Jul-08 4:21 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 20,107 | $42.05 | $845,499.00 | 1074% 1.87K to 21.98K | 85% |
| 18-Jul-08 4:37 PM View: | Juelsgaard Stephen G EVP, CCO & SECRETARY | Genentech Inc. (DNA) | 16-Jul-08 | Market Option Sale | 8,366 | $79.32 | $663,631.00 | (60%) 13.83K to 5.47K | (18%) |
| 18-Jul-08 4:22 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Option Exercise | 30,817 | $53.23 | $1,640,390.00 | 1490% 2.07K to 32.88K | 46% |
| 18-Jul-08 4:20 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Market Option Sale | 16,919 | $79.51 | $1,345,220.00 | (90%) 18.79K to 1.87K | (18%) |
| 18-Jul-08 4:21 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Market Sale | 1,300 | $80.00 | $103,996.00 | (57%) 2.27K to 0.97K | (17%) |
| 18-Jul-08 4:22 PM View: | Clark Ian T EVP-COMMERCIAL | Genentech Inc. (DNA) | 16-Jul-08 | Market Sale | 1,400 | $80.35 | $112,488.00 | (68%) 2.07K to 0.67K | (17%) |
| 18-Jul-08 12:33 PM View: | Tessier-Lavigne Marc EVP, RESEARCH DRUG DISCOVERY | Genentech Inc. (DNA) | 16-Jul-08 | Market Option Sale | 18,750 | $79.90 | $1,498,120.00 | (94%) 19.91K to 1.16K | (17%) |
